Medirom Healthcare TechnologMRM
13F holders, Q2 2024 (June 30)2holders +1
1new positions
0sold out
$3.93avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Medirom Healthcare Technolog (MRM) in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were UBS Group AG ($118) and Bank of America Corp. ($98).
- Company
- Medirom Healthcare Technolog
- CUSIP
- 58510H103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $118 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 30 shares bought and 382 shares sold, net −352 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| UBS Group AG | 0.00% | New | 30 | $118 |
| Bank of America Corp. | 0.00% | Reduce -93.9% | 25 | $98 |
"% of holder's portfolio" is MRM's weight in each manager's 13F, not the share of Medirom Healthcare Technolog the manager owns.